Direktorat Registrasi ObatValid

PAPAVERINE HYDROCHLORIDE

Claim this product
BPOM Number
GKL0434003710A1
Approved
21 November 2024
Expiry
24 February 2029
Form
TABLET; 40.00 MG

About This Registration

PAPAVERINE HYDROCHLORIDE is a BPOM-registered direktorat registrasi obat in Indonesia, registered under number GKL0434003710A1. Its current registration status is Valid, with the licence valid until 24 February 2029. The product is registered to NOVAPHARIN - INDONESIA. BPOM first approved this registration in June 2024. All registration data is sourced directly from the official BPOM public database and updated daily.

Registration Details

Application
Registrasi Obat
Packaging
DUS, 10 STRIP @ 10 TABLET
Department
Direktorat Registrasi Obat

Retail Audit Service

Get detailed market intelligence for this product across Indonesian retail channels

Multiple cities available
Custom questionnaires
Professional shoppers
Detailed reporting
Starting from $50 per city
What's included in the audit service?

Stock availability and positioning verification

Price checking and competitor analysis

Display quality and promotional material assessment

Store condition and customer experience evaluation

Custom questions tailored to your research needs

Professional photographs and detailed reports

Ingredients (1)

PAPAVERINE HYDROCHLORIDE

Market Intelligence

Owner Portfolio
NOVAPHARIN - INDONESIA holds 165 BPOM registrations
Manufacturer Scale
NOVAPHARIN - INDONESIA produces 165 registered products
Registration Age
Registered for 2 years, 3 months

FDA Cross-Reference

via openFDA
Generic Name
PAPAVERINE HYDROCHLORIDE
Product Type
HUMAN PRESCRIPTION DRUG
Route of Administration
INTRAMUSCULAR

Data sourced from the U.S. FDA drug label database (openFDA). May not exactly match this product variant.

Is this your product?

Claim it to manage registration, track renewals, and get expiry alerts.

Claim Product
1